Ocata Therapeutics Inc fka OCAT

[Streett]

Financials will be troublesome for anyone who isn't really ontop of this company. Anything short of a signed JV will be so because they have no income and are spending money on the trials monthly.

I think they are doing things this way so that people can absorb the "worst" of it tonight and sleep on it without being able to rush into a reactive sell that they might think twice about once they hear the conference call.

Then, the conference call will contain some good stuff that people can take with them as they make trading decisions tomorrow.

They can put the two together over the weekend.

CW